Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

Ischemic stroke continues to be one of the most challenging diseases in translational neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for acute ischemic stroke, but its use is limited to the first hours after stroke onset due to an increased risk of hemorrhagic tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhan, Shaheen E., Kirchgessner, Annette, Tepper, Deborah, Leonard, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615191/
https://www.ncbi.nlm.nih.gov/pubmed/23565108
http://dx.doi.org/10.3389/fneur.2013.00032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615191/
https://www.ncbi.nlm.nih.gov/pubmed/23565108
http://dx.doi.org/10.3389/fneur.2013.00032

Ejemplares similares